Analytical Study of Primary Health care in Developing Countries | Original Article

ABSTRACT:

There have been recurring issues between medicine (treatment) and public health (prevention). This is mainly due to heavy competition on the development of value-added medicines by most modernized pharmaceutical companies. Most of the medicines have been manufactured under the strict guidelines of international monitoring agencies, in order to keep safety and security. Medicines are for maintenance of health care at different stages of the life cycle. Irrespective of cost, medicines are used at primary, secondary, and territory levels of health treatment. Contemporary medicine applies biomedical sciences, biomedical research to diagnose, treat, and prevent injury and disease. But, due to the cost and market availability, it is not possible to use many lifesaving biologics. Primary health-care medical services are extended by physicians, physician assistants, nurses, or other health professionals who have the first contact with a patient seeking medical treatment or care. About 90 of medical visits can be treated by the primary care provider. These include treatment of acute and chronic illnesses, preventive care, and health education for all ages and both sexes. Availability of medicines and clinical practice varies across different geographic locations of the world, and the availability and cost of medicines vary accordingly. Biologic drugs are highly developed in the Western world. While in developing countries such as Asia-pacific and Africa, the population relies on traditional pharmaceutical medicines due to their low cost.